SOP for Incorporation of Stabilizers in Nanoparticle-Based Formulations

Standard Operating Procedure for Incorporation of Stabilizers in Nanoparticle-Based Formulations

1) Purpose

This SOP outlines the procedure for incorporating stabilizers into nanoparticle formulations to enhance the physical and chemical stability of the nanoparticles, preventing aggregation and degradation during storage and application.

2) Scope

This SOP applies to personnel involved in the preparation and stabilization of nanoparticles used in pharmaceutical, biomedical, and industrial applications.

3) Responsibilities

Operators: Responsible for adding stabilizers to nanoparticle formulations as per the outlined procedure.
QA: Ensures that the nanoparticle formulations meet stability requirements during storage and application.

4) Procedure

4.1 Selection of Stabilizers

4.1.1 Types of Stabilizers

4.1.1.1 Select stabilizers such as surfactants (e.g., Tween 80, Pluronic), polymers (e.g., PEG, PVP), or natural stabilizers (e.g., lecithin) to prevent nanoparticle aggregation and maintain stability.

4.1.2 Concentration Optimization

4.1.2.1 Optimize the concentration of the stabilizer to ensure effective protection against aggregation without interfering with the nanoparticle’s drug delivery or functional properties.

4.2 Incorporation of Stabilizers

4.2.1 Mixing Procedure

4.2.1.1 Dissolve the stabilizer in the nanoparticle suspension or add it during the nanoparticle synthesis process to ensure homogenous mixing and adequate coverage of the nanoparticle surface.

4.2.2 Sonication or Stirring

4.2.2.1 Use sonication or stirring to ensure proper dispersion of the stabilizer and nanoparticles, preventing aggregation.

4.3 Testing for Stability

4.3.1 Particle

Size Analysis

4.3.1.1 Measure the particle size before and after adding stabilizers using dynamic light scattering (DLS) to ensure that the nanoparticles remain within the desired size range.

4.3.2 Stability Testing

4.3.2.1 Conduct stability testing under different environmental conditions (e.g., temperature, humidity) to confirm that the stabilizers maintain nanoparticle integrity.

4.4 Storage

4.4.1 Storage Conditions

4.4.1.1 Store the stabilized nanoparticle formulations in sealed, sterile containers at 4°C or room temperature, depending on the type of formulation and stability data.

5) Abbreviations, if any

PEG: Polyethylene Glycol
PVP: Polyvinylpyrrolidone
DLS: Dynamic Light Scattering

6) Documents, if any

Stabilizer Addition Logbook

7) References, if any

Guidelines for nanoparticle stabilization and formulation

8) SOP Version

Version 1.0

Annexure

Stabilizer Addition Logbook Template


  
    Date
    Batch Number
    Stabilizer Used
    Concentration
    Particle Size (After Stabilization)
    Operator Initials
    QA Initials
  
  
    DD/MM/YYYY
    Batch Number
    Stabilizer Name
    Concentration (w/v %)
    Size in nm
    Operator Name
    QA Name